Neuried, Germany, 10 June 2025 – AMSilk, a global leader in advanced biomaterials based on silk proteins, today announces its expansion into the consumer care market with the launch of AMSilk4Shine and AMSilk4Care. AMSilk4Shine is an innovative, silk protein-based ingredient designed to provide a more sustainable, high-performance alternative to traditional petroleum-based polymers which are for […]
We hope you are enjoying Optimum’s weekly newsletter – subscribe on LinkedIn today so you never miss an edition. Our clients Loqus23 Therapeutics and Ona Therapeutics continued the stream of good news for February with key leadership appointments. LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors LoQus23 Therapeutics Ltd, […]
Neuried, Germany, 16 October 2024: AMSilk GmbH (“AMSilk”/ the Company), a frontrunner in advanced biomaterials made from spider silk-based proteins, today announces that the Company and Ajinomoto Foods Europe, a company with over 50 years of experience in industrial fermentation and the affiliate of the globally established Ajinomoto Group, have expressed mutual interest to step […]
Neuried, Germany, 03 September 2024: AMSilk GmbH (“AMSilk”), a global leader in advanced biomaterials made from spider silk-based proteins, today announces it has been invited to join the World Economic Forum’s Global Innovators Community. The Global Innovators Community, an invite-only initiative, was established in 2019 to bring together companies making strides to innovate and contribute […]
Neuried, Germany, 25 June 2024: AMSilk GmbH (“AMSilk”), a frontrunner in advanced biomaterials made from spider silk-based proteins, today announces that it will be making its first appearance at Première Vision Paris, the largest textile trade show in Europe, from the 2-4 July 2024. Première Vision Paris, an international event for creative and eco-responsible fashion […]
